The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Therapeutic Efficacy-Potentiated and Diseased Organ-Targeting Nanovesicles Derived from Mesenchymal Stem Cells for Spinal Cord Injury Treatment
Abstract
Human mesenchymal stem cell (hMSC)-derived exosomes have been spotlighted as a promising therapeutic agent for cell-free regenerative medicine. However, poor organ-targeting ability and insufficient therapeutic efficacy of systemically injected hMSC-exosomes were identified as critical limitations for their further applications. Therefore, in this study we fabricated iron oxide nanoparticle (IONP)-incorporated exosome-mimetic nanovesicles (NV-IONP) from IONP-treated hMSCs and evaluated their therapeutic efficacy in a clinically relevant model for spinal cord injury. Compared to exosome-mimetic nanovesicles (NV) prepared from untreated hMSCs, NV-IONP not only contained IONPs which act as a magnet-guided navigation tool but also carried greater amounts of therapeutic growth factors that can be delivered to the target cells. The increased amounts of therapeutic growth factors inside NV-IONP were attributed to IONPs that are slowly ionized to iron ions which activate the JNK and c-Jun signaling cascades in hMSCs. In vivo systemic injection of NV-IONP with magnetic guidance significantly increased the amount of NV-IONP accumulating in the injured spinal cord. Accumulated NV-IONP enhanced blood vessel formation, attenuated inflammation and apoptosis in the injured spinal cord, and consequently improved spinal cord function. Taken together, these findings highlight the development of therapeutic efficacy-potentiated extracellular nanovesicles and demonstrate their feasibility for repairing injured spinal cord.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a clinically relevant model of SCI, the systemic delivery of NV-IONP, directed by magnetic targeting, significantly increased their accumulation at the lesion site.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [295]
Citations
Cites
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Wiklander, O. P. B., Nordin, J. Z., O'Loughlin, A., Gustafsson, Y., Corso, G., Mäger, I., Vader, P., Lee, Y., Sork, H., Seow, Y., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.26316 · Cited by 1,730
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine
Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091852 · Cited by 1,363
Fischer, U. M., Harting, M. T., Jimenez, F., Monzon-Posadas, W. O., Xue, H., Savitz, S. I., Laine, G. A., & Cox, C. S. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0253 · Cited by 1,292
Arslan, F., Lai, R. C., Smeets, M. B., Akeroyd, L., Choo, A. B. H., Aguor, E. N. E., Timmers, L., van Rijen, H. V. M., Doevendans, P. A., Pasterkamp, G., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.01.002 · Cited by 1,137
Jang, S. C., Kim, O. Y., Yoon, C. M., Choi, D., Roh, T., Park, J., Nilsson, J. A., Lötvall, J. O., Kim, Y., & Gho, Y. S. (2013) · ACS Nano · doi:10.1021/nn402232g · Cited by 1,037
Lee, N., & Hyeon, T. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15248c · Cited by 995
Self-citationDynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter
Lai, C. P., Mardini, O., Ericsson, M., Prabhakar, S., Maguire, C. A., Chen, J. W., Tannous, B. A., & Breakefield, X. O. (2014) · ACS Nano · doi:10.1021/nn404945r · Cited by 913
Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo
Jetten, N., Verbruggen, S. E. L., Gijbels, M. J., Post, M. J., de Winther, M. P. J., & Donners, M. M. P. C. (2013) · Angiogenesis · doi:10.1007/s10456-013-9381-6 · Cited by 871
Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade
Oyinbo, C. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1848 · Cited by 788
Exosomes Derived from Mesenchymal Stem Cells
Yu, B., Zhang, X., & Li, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034142 · Cited by 788
Lübbe, A. S., Bergemann, C., Riess, H. B., Schriever, F., Reichardt, P., Possinger, K., Matthias, M., Dörken, B., Herrmann, F., Gürtler, R., et al. (1996) · PubMed · Cited by 652
Nor, J. E., Christensen, J. B., Mooney, D. J., & Polverini, P. J. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65284-4 · Cited by 645
Zhang, F., Wang, H., Wang, X., Jiang, G., Liu, H., Zhang, G., Wang, H., Fang, R., Bu, X., Cai, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10561 · Cited by 580
Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes
Katsuda, T., Tsuchiya, R., Kosaka, N., Yoshioka, Y., Takagaki, K., Oki, K., Takeshita, F., Sakai, Y., Kuroda, M., & Ochiya, T. (2013) · Scientific Reports · doi:10.1038/srep01197 · Cited by 579
Sicco, C. L., Reverberi, D., Balbi, C., Ulivi, V., Principi, E., Pascucci, L., Becherini, P., Bosco, M. C., Varesio, L., Franzin, C., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0363 · Cited by 579
Anderson, J. D., Johansson, H. J., Graham, C. S., Vesterlund, M., Pham, M. T., Bramlett, C. S., Montgomery, E. N., Mellema, M., Bardini, R. L., Contreras, Z., et al. (2016) · Stem Cells · doi:10.1002/stem.2298 · Cited by 546
Exosomes: New players in cell–cell communication
Bang, C., & Thum, T. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.007 · Cited by 517
Mesenchymal‐stem‐cell‐derived exosomes accelerate skeletal muscle regeneration
Nakamura, Y., Miyaki, S., Ishitobi, H., Matsuyama, S., Nakasa, T., Kamei, N., Akimoto, T., Higashi, Y., & Ochi, M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.03.031 · Cited by 511
The therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles
Katsuda, T., Kosaka, N., Takeshita, F., & Ochiya, T. (2013) · PROTEOMICS · doi:10.1002/pmic.201200373 · Cited by 432
Tomasoni, S., Longaretti, L., Rota, C., Morigi, M., Conti, S., Gotti, E., Capelli, C., Introna, M., Remuzzi, G., & Benigni, A. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0266 · Cited by 345
Huang, J., Yin, X.-M., Xu, Y., Xu, C., Lin, X., Ye, F., Cao, Y. B., & Lin, F. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5063 · Cited by 293
Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis
Bai, L., Shao, H., Wang, H., Zhang, Z., Su, C., Dong, L., Yu, B., Chen, X., Li, X., & Zhang, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-04559-y · Cited by 280
c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer
Vleugel, M. M., Greijer, A. E., Bos, R., van der Wall, E., & van Diest, P. J. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.01.022 · Cited by 250
Large-scale generation of cell-derived nanovesicles
Jo, W., Kim, J., Yoon, J., Jeong, D., Cho, S., Jeong, H., Yoon, Y. J., Kim, S., Gho, Y. S., & Park, J. (2014) · Nanoscale · doi:10.1039/c4nr02391a · Cited by 239
Self-citationNoninvasive imaging of radiolabeled exosome-mimetic nanovesicle using 99mTc-HMPAO
Hwang, D. W., Choi, H., Jang, S. C., Yoo, M. Y., Park, J. Y., Choi, N. E., Oh, H. J., Ha, S., Lee, Y., Jeong, J. M., et al. (2015) · Scientific Reports · doi:10.1038/srep15636 · Cited by 234
Wilson, M. W., Kerlan, R. K., Fidelman, N. A., Venook, A. P., LaBerge, J. M., Koda, J., & Gordon, R. L. (2004) · Radiology · doi:10.1148/radiol.2301021493 · Cited by 190
Biotransformations of magnetic nanoparticles in the body
Kolosnjaj‐Tabi, J., Lartigue, L., Javed, Y., Luciani, N., Pellegrino, T., Wilhelm, C., Alloyeau, D., & Gazeau, F. (2016) · Nano Today · doi:10.1016/j.nantod.2015.10.001 · Cited by 166
Zhou, Z., Chen, Y., Zhang, H., Min, S., Yu, B., He, B., & Jin, A. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2012.11.015 · Cited by 145
Han, J., Kim, B.-K., Shin, J.-Y., Ryu, S., 노명경, Woo, J., Park, J.-S., Lee, Y., Lee, N., Hyeon, T., et al. (2015) · ACS Nano · doi:10.1021/nn506732n · Cited by 141
Self-citationERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling
Winter, J. N., Jefferson, L. S., & Kimball, S. R. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00504.2010 · Cited by 135
Fibronectin Matrix Assembly after Spinal Cord Injury
Zhu, Y., Soderblom, C., Trojanowsky, M., Lee, D.-H., & Lee, J. K. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3703 · Cited by 123
Self-citationConditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis
Shen, C., Lie, P., Miao, T.-Y., Yu, M., Lu, Q., Feng, T., Li, J.-R., Zu, T., Liu, X., & Li, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3409 · Cited by 122
Roles of Mesenchymal Stem Cells in Spinal Cord Injury
Qu, J., & Zhang, H. (2017) · Stem Cells International · doi:10.1155/2017/5251313 · Cited by 115
Cell therapy for spinal cord regeneration
Willerth, S. M., & Sakiyama‐Elbert, S. E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.028 · Cited by 111
Extracellular Vesicle-Shuttled mRNA in Mesenchymal Stem Cell Communication
Ragni, E., Banfi, F., Barilani, M., Cherubini, A., Parazzi, V., Larghi, P., Dolo, V., Bollati, V., & Lazzari, L. (2017) · Stem Cells · doi:10.1002/stem.2557 · Cited by 108
Gao, Q., Li, Y., & Chopp, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.091 · Cited by 102
Enhancing the efficacy of mesenchymal stem cell therapy
Mastri, M. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i2.82 · Cited by 102
Potential Therapies by Stem Cell‐Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche
Luarte, A., Bátiz, L. F., Wyneken, Ú., & Lafourcade, C. (2016) · Stem Cells International · doi:10.1155/2016/5736059 · Cited by 100
Yao, Y., Huang, J., Geng, Y., Qian, H., Wang, F., Liu, X., Shang, M., Nie, S., Liu, N., Du, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129164 · Cited by 90
Multiple neurotrophic effects of VEGF on cultured neurons
Sanchez, A. C., Wadhwani, S., & Grammas, P. (2010) · Neuropeptides · doi:10.1016/j.npep.2010.04.002 · Cited by 58
Folkman, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh148 · Cited by 36
Li, S., Qi, Y., Hu, S., Piao, F., Guan, H., Wang, Z.-M., Chen, R., & Liu, S. (2015) · Toxicology and Industrial Health · doi:10.1177/0748233715598267 · Cited by 18
Flagged first, then by citations
Research works printed but not linked: 1
- Lubbe A. S., 1996, Cancer Res., 56, 4686
Cited by
Sorted by citations
Engineered Extracellular Vesicles for Cancer Therapy
Zhang, X., Zhang, H., Gu, J., Zhang, J., Shi, H., Qian, H., Wang, D., Xu, W., Pan, J., & Santos, H. A. (2021) · Advanced Materials · doi:10.1002/adma.202005709 · Cited by 428
Polydopamine Decorated Microneedles with Fe‐MSC‐Derived Nanovesicles Encapsulation for Wound Healing
Ma, W., Zhang, X., Liu, Y., Fan, L., Gan, J., Liu, W., Zhao, Y., & Sun, L. (2022) · Advanced Science · doi:10.1002/advs.202103317 · Cited by 359
Artificial exosomes for translational nanomedicine
Li, Y.-J., Wu, J.-Y., Liu, J., Xu, W., Qiu, X., Huang, S., Hu, X.-B., & Xiang, D.-X. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00986-2 · Cited by 303
Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell‐free therapy
Phan, J., Kumar, P., Hao, D., Gao, K., Farmer, D. L., & Wang, A. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1522236 · Cited by 336
Kim, H. Y., Kim, T. J., Kang, L., Kim, Y. J., Kang, M. K., Kim, J., Ryu, J. H., Hyeon, T., Yoon, B., Ko, S., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119942 · Cited by 320
Self-citation
Metadata
- Authors
- Kim, H. Y., Kumar, H., Jo, M.-J., Kim, J., Yoon, J.-K., Lee, J.-R., Kang, M., Choo, Y. W., Song, S. Y., Kwon, S. P., Hyeon, T., Han, I.-B., & Kim, B.-S.
- Affiliations
- Seoul National University (KR)
- CHA University Bundang Medical Center (KR)
- Department of Neurosurgery, CHA University, CHA Bundang Medical Center, Seongnam-si, 13488, Republic of Korea
- Corresponding author
- Kim, Byung-Soo
- ORCID
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-07-11
- Volume
- 18
- Issue
- 8
- Pages
- 4965-4975
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2825453881
- Cited by
- 190
- References
- 44
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 32 · 2023: 27 · 2022: 34 · 2021: 37 · 2020: 23 · 2019: 9 · 2018: 3
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nano Letters (publishedVersion)
- PubMed (publishedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- Korea Health Industry Development Institute (HI18C0183)
- National Research Foundation of Korea (2017R1A2B3005842, 2017R1C1B1011397)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- mesenchymal stem cell-derived exosomes, iron oxide nanoparticles, magnetic targeting, spinal cord injury, JNK/c-Jun signaling, iron release, growth factor delivery, angiogenesis, neuroinflammation, apoptosis
- MeSH terms
- Animals, Drug Carriers, Humans, Spinal Cord Injuries, Signal Transduction, PC12 Cells, Apoptosis, Neovascularization, Physiologic, Intercellular Signaling Peptides and Proteins, Biomimetic Materials, Mice, Rats, Exosomes, Magnetite Nanoparticles, Mesenchymal Stem Cells, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
